comparemela.com

Latest Breaking News On - பெண்கள் மருத்துவர்கள் ஆர்கநைஸேஶந் - Page 1 : comparemela.com

Study finds women with osteoporosis and low bone density are at increased risk of hearing loss

 E-Mail BOSTON Hearing loss is the third most common chronic health condition in the United States. Previous studies of people with hearing loss have uncovered higher prevalence of osteoporosis a disease in which the bones become weak and brittle and low bone density (LBD). But research on whether these conditions may influence risk of hearing loss over time is scarce. It is also unknown whether hearing loss can be avoided by taking bisphosphonates, the primary medication used to prevent fractures in people with reduced bone density. As part of the Conservation of Hearing Study (CHEARS), researchers from Brigham and Women s Hospital analyzed data from nearly 144,000 women who were followed for up to 34 years. They found that risk of subsequent moderate or worse hearing loss was up to 40 percent higher in study participants with osteoporosis or LBD. The study, published in the

Scituate resident hired as South Shore Health s chief operating officer

Scituate resident hired as South Shore Health s chief operating officer William C. Johnston will join the health system’s leadership team in June. “We are so excited to welcome Bill to the South Shore Health team,” South Shore Health President & CEO Allen L. Smith said in a statement. “His deep clinical, business and leadership experience will prove essential as we pursue performance improvement measures and strategic clinical affiliations that will ensure our system can adapt to a rapidly changing health care landscape. I know he embraces our mission to be the first place our community turns to for their health and wellness needs.”

Real world data reveal risks of allergic reactions after receiving COVID-19 mRNA vaccines

 E-Mail BOSTON - Almost immediately after the first mRNA-based COVID-19 vaccines were authorized for emergency use and were administered to individuals outside of clinical trials, reports of anaphylaxis a life-threatening whole-body allergic reaction raised widespread concerns among experts and the public. Now, real world data on vaccinations among employees at Mass General Brigham provide reassurances of the rarity of such serious reactions, and the ability to recover from them. The findings are published in the The COVID-19 mRNA vaccines are the first vaccines of their kind, and they have remarkable efficacy and safety across all populations. It is critical to have accurate information on allergic reactions to these vaccines, not only for our current situation, but also because this new vaccine platform is so important for future pandemic responses, says lead author Kimberly Blumenthal, MD, MSc, co-director of the Clinical Epidemiology Program within Massachusetts General Hos

© 2025 Vimarsana

vimarsana © 2020. All Rights Reserved.